Related Experiment Video

Updated: Jul 4, 2025

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

143

Encouraging data on rituximab in polymyalgia rheumatica

Maria Sandovici1, Kornelis S M van der Geest1, Mieke A M H Boots1

  • 1Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen 9700 RB, Netherlands.

The Lancet. Rheumatology
|February 1, 2024
PubMed
Summary

No abstract available in PubMed .

More Related Videos

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

17.8K
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

114

Related Experiment Videos

Last Updated: Jul 4, 2025

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

143
In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

17.8K
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

114

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K

Articles linked to this work by shared authors, journal, and citation graph.

Genetic biomarkers of clinical manifestations in giant cell arteritis define distinct patient subgroups.

Annals of the rheumatic diseases·2026

A Delphi survey of patients and clinicians on a unified and stratified approach to managing GCA-PMR spectrum disease.

Rheumatology (Oxford, England)·2026

Challenges and Future Trends in Large Vessel Vasculitis.

Circulation·2026

PET imaging of large-vessel vasculitis: advancements and future trends.

Seminars in nuclear medicine·2026

Vascular imaging as an endpoint in clinical trials of giant cell arteritis.

Clinical and experimental rheumatology·2026

PET imaging of polymyalgia rheumatica: update and future trends.

Seminars in nuclear medicine·2026

Impact of BMI on response to Janus kinase inhibitors in rheumatoid arthritis: an individual patient data meta-analysis of randomised controlled trials.

The Lancet. Rheumatology·2026

The erosion of seronegative autoimmune diseases through the lens of autoantibodies.

The Lancet. Rheumatology·2026

When and how chronicity develops in rheumatoid arthritis: towards a temporal and tissue-integrated perspective.

The Lancet. Rheumatology·2026

Interferon-α as a precision medicine tool in Sjögren's disease: a cohort and experimental medicine study.

The Lancet. Rheumatology·2026

Long-term durability of a time-limited methotrexate intervention in patients with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative arthralgia at increased risk for rheumatoid arthritis (TREAT EARLIER): 5-year data from a double-blind, randomised, placebo-controlled trial.

The Lancet. Rheumatology·2026

Predicting psoriatic arthritis in new-onset psoriasis: development of multivariable prediction models from an inception cohort study.

The Lancet. Rheumatology·2026

Association of combined near-infrared autofluorescence and indocyanine green angiography with immediate and permanent postoperative hypoparathyroidism after thyroid surgery: a propensity score-matched analysis.

Updates in surgery·2026

The Causal Relationship between Antibody Immune Response and Ischemic Stroke: A Mendelian Randomization Analysis.

Endocrine, metabolic & immune disorders drug targets·2026

All Is Swell: A Case Report of Insulin Edema Syndrome.

Cureus·2026

Anti-C2-mediated complement inhibition prevents disease in a rat passive transfer model of myasthenia gravis.

Journal of translational autoimmunity·2026

Targeting macrophage-mediated TGF-β/BMP signaling in ankylosing spondylitis: from inflammation to pathological bone formation.

Frontiers in immunology·2026

Oxidative Post-Translational Modifications of Insulin in Type 1 Diabetes Autoimmunity.

Immunological reviews·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us